Patents by Inventor Roberto Accinni

Roberto Accinni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antioxidant composition comprising polydatin and acetylcysteine
    Patent number: 11951117
    Abstract: Antioxidant composition for increasing the levels of vitamins and reducing oxidative damage in a subject; the composition comprises an active agent, containing polydatin and acetylcysteine.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: April 9, 2024
    Assignee: SOLONGEVITY NUTRACEUTICALS S.R.L.
    Inventor: Roberto Accinni
  • CALORIC RESTRICTION MIMETIC COMPOSITIONS
    Publication number: 20230149334
    Abstract: Caloric restriction mimetic compositions comprising an active agent; the active agent comprises acetylcysteine, at least one compound selected in the group consisting of nicotinamide, nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), at least one compound selected between polydatin and resveratrol.
    Type: Application
    Filed: April 8, 2021
    Publication date: May 18, 2023
    Inventors: Roberto ACCINNI, Priscilla BISWAS, Alberto BERETTA
  • ANTIOXIDANT COMPOSITION COMPRISING POLYDATIN AND ACETYLCYSTEINE
    Publication number: 20220117986
    Abstract: Antioxidant composition for increasing the levels of vitamins and reducing oxidative damage in a subject; the composition comprises an active agent, containing polydatin and acetylcysteine.
    Type: Application
    Filed: February 21, 2020
    Publication date: April 21, 2022
    Inventor: Roberto ACCINNI
  • Breast cancer antigens
    Patent number: 4383985
    Abstract: Tumor associated antigens are disclosed in both crude and pure form which are specific to human breast cancer. The antigens are designated BCA. Antisera, radiolabeled antigens and antisera, as well as methods for the detection of circulating BCA are also disclosed. Methods for the extraction of BCA also form part of the invention. A diagnostic kit for the detection of circulating BCA, especially one suitable for use in as radioimmunoassay is also disclosed.
    Type: Grant
    Filed: July 11, 1980
    Date of Patent: May 17, 1983
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Alberto Bartorelli, Roberto Accinni